Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1Breast 1

Conditions

Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Virtual Reality Exposure Therapy × Clear all
NCT05135260 2024-10-16

Virtual Reality on Pain, Stress, and Affect in the Infusion Clinic

Vanderbilt-Ingram Cancer Center

Phase NA Completed
99 enrolled
Tumor-Agnostic

Neoplasms

NCT04419077 2023-09-05

REV

Hospices Civils de Lyon

Phase NA Completed
41 enrolled
BreastHead & Neck

Anxiety Disorders, Breast Neoplasms, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡